The type II phosphatidylinositol 4-kinases (PI4KIIs) produce the lipid phosphatidylinositol 4-phosphate (PtdIns4P) and participate in a confusing variety of membrane trafficking and signaling roles. This review argues that both historical and contemporary evidence supports the function of the PI4KIIs in numerous trafficking pathways, and that the key to understanding the enzymatic regulation is through membrane interaction and the intrinsic membrane environment. By summarizing new research and examining the trafficking roles of the PI4KIIs in the context of recently solved molecular structures, I highlight how mechanisms of PI4KII function and regulation are providing insights into the development of cancer and in neurological disease. I present an integrated view connecting the cell biology, molecular regulation, and roles in whole animal systems of these increasingly important proteins.
Introduction
The phosphatidylinositol 4-kinases (PI4Ks) occupy a central position in phosphatidylinositol (PtdIns) metabolism because they catalyze the first step in the biosynthesis of four of the seven phosphoinositide (PI) lipids, [1] all of which are intimately involved in membrane trafficking. [2, 3] Their primary enzymatic product, phosphatidylinositol 4-phosphate (PtdIns4P), is a signaling precursor and an important regulator of membrane traffic [3] that can be produced by either of the four PI4K activities. The extensively studied type III PI4Ks (PI4KIIIα and PI4KIIIβ) were the first PI4K enzymes to be identified at the molecular level and these isoforms produce PtdIns4P at the plasma membrane (PM) and Golgi, respectively (reviewed in depth elsewhere [4, 5] ). The type II PI4KIIs (PI4KIIα and PI4KIIβ) were identified more recently [6, 7] and we are only now beginning to understand in detail how they influence membrane identity and trafficking.
PI4KII was first described decades ago as a membrane-bound enzyme activated by non-ionic detergents and inhibited by adenosine. [6, 7] For many years, interest in PI4K activities was driven by their requirement in PtdIns-(4,5)P 2 -dependent signaling at the plasma membrane. However, recent years have seen profound advances in our understanding of PI4KII in membrane trafficking that have largely eclipsed the role of PI4KII in signaling. The functions of PtdIns4P have also expanded into a much broader subcellular distribution than previously envisaged. Discrete pools of PtdIns4P outside of the Golgi are now recognized on early (EE) and sorting endosomes (SEs), late endosomes (LEs), at the plasma membrane (PM) [8] [9] [10] and even on different subdomains of the transGolgi network (TGN)-endosomal system [11] ( Figure 1) . The PI4KIIα and PI4KIIβ enzymes have also been detected at the PM and in endosomal compartments containing PtdIns4P. Subcellular distribution of both PI4KII isoforms and the PIs they produce is therefore broad and overlapping, leading to questions of whether the enzymes have redundant functions.
We now have much information relating to the trafficking events controlled by these enzymes and the PtdIns4P they synthesize. The recently solved structures of the PI4KII isoforms place their hitherto mysterious properties into a molecular framework, thereby allowing us to rationalize their functions and explain the unique biochemistry of these two key PI kinases. This review discusses the structure and function of the PI4KIIs, the differences and similarities in their regulation and their involvement in physiological processes and disease.
The PI4KIIs are an Ancient Kinase Family
The PI4KII family eluded molecular identification for many years because their gene sequences differed from those of known PI kinases. [12, 13] Discovery of the alpha isoform (PI4KIIα) revealed an unexpected second isoform that we termed PI4KIIβ. [13] The PI4KIIs are distinct from the PI4KIII family whose members are clearly homologous to the archetypal protein kinase PKA and the PI3Ks, thereby placing the PI4KII structures unequivocally within the PI3K/protein kinase superfamily. [5] Three-dimensional structures of recombinant human PI4KIIα have been reported recently [14, 15] and the data subjected to extensive molecular modeling to predict biochemical behavior of the proteins. These studies illustrate how the enzymes differ from the phosphoinositide 3-kinase (PI3K) superfamily and how the PI4KIIs interact with membranes. The structures also offer explanations for several unique biochemical properties of the PI4KIIs such as sensitivity to detergent, cholesterol, and adenosine that were first described during the characterization of purified PI4KII activity. The models also provide valuable insights into the regulation of PI4KII activity.
PI4KIIα has a flattened interface that contacts membranes, similar to features reported for the PI3Ks and phosphatidylinositol 4-phosphate 5-kinases (PIP5Ks), [16] suggesting that these evolutionarily distant proteins have retained a structural characteristic determining membrane interaction. Overall the catalytic domain of PI4KIIα is similar to PI3Ks in that it is composed of N-and C-terminal lobes ( Figure 2A ) but with additional insertions not found in PI3Ks. A search for related structures showed that the closest relatives of PI4KIIα are protein kinases such as the Helicobacter pylori pro-inflammatory kinase CTKA, thus indicating an ancient evolutionary relationship with the protein Ser/Thr kinases.
PI4KIIα has a nucleotide-binding pocket distinct from those found in PI3Ks, which accounts for its insensitivity to PI3K inhibitors such as wortmannin. Another feature significantly different from the PI3Ks is a glycine-rich loop (G-loop) [14] that is likely to determine nucleotide-binding specificity and is potentially responsible for the sensitivity of PI4KIIα to adenosine. Co-crystallization of PI4KIIα in the presence of ADP indicates that the ATP binding pocket is positioned so that the terminal γ-phosphate is oriented in direct apposition to the membrane, where its PI substrate resides. [15] Numerous parts of the PI4KIIα molecule interact with membranes but multiple palmitoylation performs a special role by bringing a nearby amphipathic helix and the catalytic core close to the membrane ( Figure 2B ). This causes the nucleotidebinding G-loop, a putative kinase activation loop, to interact with membranes along with elements that form the PI binding pocket. [14] Together, these elements stabilize critical regions of the active site leading to a more robust kinase activity. This tight interaction with the membrane and the effect of membrane association on activity, may explain why PI4KIIα is regulated mainly by membrane composition and the availability of PtdIns substrate. [17] A second hydrophobic pocket has been identified in the C-terminal lobe of PI4KIIα [15] and, although the physiological ligand that binds this is unknown, candidates include cholesterol, an important membrane organizer and PI4KIIα regulator.
The N-termini of the PI4KIIs lack primary sequence homology, but contain protein binding sites that determine isoform-specific functions (Figure 2A) . Historically, the two PI4KII activities could not be distinguished in cell and tissue extracts and, unsurprisingly, the structure of the conserved core of PI4KIIβ is very similar to that of PI4KIIα. [18] Recently an isoform-selective small molecule inhibitor, PI-273, has been developed that is approximately 30 times more potent against PI4KIIα than PI4KIIβ. [19] This compound is capable of differentiating the two isoforms and is likely to become an important experimental tool.
PI4KII Activity is Tuned by Membrane Environment
Evidence that PI4KIIα activity is regulated comes from the finding that membranes containing low and high activity pools of the enzyme can be separated by subcellular fractionation. [20] It is clear from the three-dimensional structures that membrane interaction determines PI4KII activity, and that this is achieved through stable multiple S-palmitoylation. [21] This modification tightly anchors PI4KIIα in membranes, such that only detergent treatment can release the protein. [12] Close membrane interaction renders PI4KIIα activity exquisitely sensitive to its membrane environment, [22, 23] being activated by cholesterol [17] and phosphatidylcholine, but inhibited by acidic lipids such as phosphatidic acid. [24] The nature of this interaction is essential to understand how PI4KIIα activity responds to a changing environment, in particular the supply of PI substrate. Thus the molecular structures support numerous observations that PI4KIIα is regulated largely by intrinsic membrane factors. Figure 1 . The subcellular distribution of PtdIns4P. PtdIns4P is enriched in the Golgi complex where PI4KIIIβ, PI4KIIα, and PI4KIIβ are responsible for its synthesis. Imaging methods using recombinant proteins derived from PtdIns4P binding domains have revealed pools at the plasma membrane (PM [8] ), recycling endosome (RE, [53] ), early/sorting endosome (EE/SE, [9, 47] ), late endosome (LE, [8] ), lysosome (Lys, [8] ), autophagosome (Apg, [51] ), and phagosome (Pg, [34, 50] ). Discrete PI4K activities are responsible for this distribution and it is known that PI4KIIIα is a major PtdIns4P biosynthetic activity at the PM (yellow). PI4KIIIβ produces a pool in the Golgi apparatus (magenta), whereas PI4KIIα and PI4KIIβ produce PtdIns4P on separate domains of the TGN (red and green, respectively). [11] PI4KIIα is also responsible for pools of PtdIns4P on RE, [53] SE, LE, and Apg membranes (blue) that are likely to be dynamically regulated. Furthermore, PI4KIIα generates PtdIns4P in late phagosomes. TGN, trans-Golgi network; EE, early endosome; SE, sorting endosome; LE, late endosome; Pg phagosome; Lys, lysosome; Apg, autophagosome; EV, exocytic vesicle; RE, recycling endosome.
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PI4KIIα activity is responsible for a large proportion of total PI4K activity in cell extracts but, in contrast, PI4KIIβ activity is difficult to measure. [25] Unlike PI4KIIα, a substantial proportion of PI4KIIβ is extractable without the need for detergent [26] indicating that it is only partially membrane associated, and it is likely that this difference is key to the regulation of PI4KIIβ activity. Unlike PI4KIIα, the PI4KIIβ isoform is dynamically palmitoylated on cysteine residues within the conserved 170 CCPCC 174 motif (Figure 2A ). Membrane recruitment of PI4KIIβ is regulated and occurs in response to growth factors and on expression of constitutively active Rac1. [27] PI4KIIβ binds the molecular chaperone HSP90 through a site in the C-terminal lobe, a region that is occluded in the tightly membrane bound PI4KIIα. This interaction stabilizes cytosolic PI4KIIβ and prevents palmitoylation, and therefore membrane recruitment. Inhibition of the interaction releases PI4KIIβ leading to degradation in the proteosome ( Figure 3B ). However, acute inhibition of the interaction leads to rapid palmitoylation and translocation to TGN and plasma membranes. This interaction is likely to be regulated by external stimuli because treatment with EGF or PDGF is sufficient to disrupt the HSP90-PI4KIIβ complex. [28] Thus, it appears that both protein turnover Figure 2 . Structure of the PI4KII enzymes. A) The domain organization of PI4KIIα and PI4KIIβ is highly similar. The divergent N-termini lack homology but contain interaction sites for clathrin adaptors. In PI4KIIα, a dileucine sorting motif 57 ERQPLL 62 is recognized by AP-3 [42, 43] while PI4KIIβ contains a similar sequence ( 25 EREPLL 30 ) that specifically binds AP-1. [46] The N-ter of PI4KIIα also contains the sequence 15 PPDY 18 that binds the WW3 domain of the ubiquitin ligase Itch, which mediates multi-ubiquitination of PI4KIIα. [42] The conserved catalytic core is now known to be composed of amino-(N) and carboxy-(C) terminal lobes. Both isoforms contain a conserved palmitoylation motif, 174 CCPCC 178 in PI4KIIα and PI4KIIβ 170 CCPCC 174 . HSP90, which plays a role in the stability and membrane recruitment of PI4KIIβ, binds to a region between residues 315-481 in the C-lobe. [28] This schematic is based on the human polypeptide sequences (NP_060895 and NP_060793.2). B) Model illustrating how the PI binding pocket of palmitoylated PI4KIIα interacts with membranes (adapted with permission [14] ). Boxed area indicates palmitoylation loop.
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The Lipid Products of PI4KIIs Can be Studied at the Subcellular Level
Spatially distinct pools of PIs can be imaged at subcellular resolution by using recombinant probes that are now widely used in microscopy. [29] The use of these has confirmed the existence of PtdIns4P in the PM and, surprisingly, in multiple endosomal compartments ( [8, 10, 30] , Figure 1 ). PtdIns4P levels on intracellular membranes are determined by the localization and activity of the resident PI4Ks, but a central problem in the study of PI4KII function is that the PtdIns4P produced is indistinguishable from the enzymatic products of other PI4K isoforms. Two other issues further complicate PtdIns4P experiments: remarkably, some PtdIns4P pools can supply lipid to adjacent membranes through non-vesicular traffic, [31] making it technically difficult to assign a membrane compartment to an individual isoform; also, dynamic changes in PtdIns4P levels may not be detectable, for example, when PtdIns4P is rapidly converted to another PI. These cautions notwithstanding, cellular imaging and the manipulation of PIs has proved decisive in understanding PI4KII function. The biosynthesis of PtdIns4P by different PI4K isoforms can occur in metabolically separate pools. [10, 11] Connecting each of these pools to a particular PI4KII activity in the absence of effective inhibitors has been challenging; however, the Balla laboratory has adopted and developed techniques to acutely manipulate PIs in different organelles by the inducible targeting of PI phosphatases. [32] Thanks to this approach, which has since been used by several investigators, we know that PtdIns4P is produced in the PM by PI4KIIα [8] (as was predicted by many earlier studies [10] ), that PtdIns4P can regulate a PM calcium channel, [33] that PtdIns4P is present in LE and lysosomal membranes [8] and that PtdIns4P metabolism occurs during phagosomal maturation. [34] 
PI4KIIs Have Multiple Roles in Membrane Trafficking
Early studies indicated that the PI4KIIs localize to, and traffic between, the Golgi complex and endosomes. [20, 25, 35] It is now clear that most trafficking pathways involving PI4KIIs can be traced back to the TGN; however, to understand the multitude of PI4KII pathways, it is important to recognize the complexity of communication between the TGN and endosomal compartments, which are highly heterogeneous and ultimately traffic cargo to the lysosome or PM. [36] The TGN is itself a highly dynamic, PtdIns4P-rich compartment at the trans face of the Golgi apparatus that functions as an exit point where cargo is Figure 3 . The membrane trafficking functions of the type II PI 4-kinases. Both PI4KIIα and PI4KIIβ localize to the TGN and endosomes, although it is likely that they exist in separate domains within the TGN-endosomal system. A) PI4KIIα localizes predominantly to the TGN and endolysosomal system but relatively minor pools have also been detected at the PM. At the early/sorting endosome (EE/SE), PI4KIIα recruits AP-3 to membranes participating in traffic to the LE; however, the enzyme is also involved in retrograde traffic via a VAMP3-dependent pathway. PI4KIIα further functions in degradative pathways by producing PtdIns4P required for heterotypic fusion of lysosomal (Lys) and autophagosomal (Apg) membranes and an analogous process occurs in phagocytic cells. [34, 50] PI4KIIα mediates exocytic traffic from endosomal compartments including the EE/SE via the recycling endosome (RE) [53] and in a Rab27a-dependent step from the LE during HIV-1 viral assembly in T-cells. [80] B) PI4KIIβ is partially cytosolic and is dynamically palmitoylated in response to growth factors and expression of constitutively active Rac, which both lead to PM recruitment. PI4KIIβ synthesises a pool of PtdIns4P that colocalises with TGN46 (green [11] ). At the TGN, PI4KIIβ is responsible for recruitment of the clathrin adaptor AP-1. [46] The molecular chaperone HSP90 binds PI4KIIβ preventing palmitoylation, thereby maintaining PI4KIIβ in an inactive, cytosolic form while protecting the protein from proteosomal degradation.
sorted into biosynthetic and endosomal pathways. The TGN also receives backward (retrograde) traffic from endosomal compartments. [37] The TGN therefore, plays critical functions as a sorting hub that coordinates many aspects of intracellular traffic, including secretion and the biogenesis of lysosomes and related organelles. PI4KIIα, PI4KIIβ, and the PtdIns4P the enzymes produce, all function at the TGN and associated membranes, and the following sections describe how the PI4KIIs function in these processes.
How the PI4KIIs Control Traffic
PtdIns4P is a factor in the recruitment of several clathrin adaptors at the TGN and therefore in determining the sorting of proteins into distinct pathways. For example, EpsinR is a PtdIns4P-binding protein that mediates TGN-to-endosome cargo sorting, [38] as are the Golgi-localized γ-ear-containing Arf binding proteins (GGAs), [39] which require PtdIns4P synthesized by PI4KIIα for correct localization. [40] PI4KIIα is a significant PtdIns4P biosynthetic activity at the TGN and it was originally reported that depletion of the enzyme delocalizes the clathrin adaptor and PtdIns4P effector AP-1, [41] which principally directs TGN-to-endosomal traffic. However, subsequent studies have failed to demonstrate colocalization or direct interaction between PI4KIIα and AP-1. [9, 42, 43] Instead PI4KIIα forms a direct complex with another adaptor, AP-3, via its dileucine interaction motif 56 ERQPLL 61 [43] (Figure 2A ). AP-3 controls traffic from EE/SE into the endolysosomal pathway. [44] The finding that PI4KIIα is a component of AP-3 containing vesicles, along with many AP-3 cargoes, [45] further supports the involvement of PI4KIIα in EE/SE-to-LE traffic ( Figure 3A) .
PI4KIIβ is also found in the TGN where it colocalizes with AP-1, and to a lesser degree with EE and LE markers, indicating that PI4KIIβ is distributed between the TGN and endosomal systems. PI4KIIβ contains the N-terminal dileucine sequence 25 EREPLL 30 that specifically binds AP-1, rather than AP-3. [46] This AP-1 complex is required to localize PI4KIIβ to the TGN and PI4KIIβ knockdown causes mislocalization of AP-1, indicating that the proteins are functionally interdependent. Importantly, by virtue of their adaptor recognition motifs, both PI4KII isoforms are effectively cargoes that promote the recruitment of their cognate adaptors. In the case of PI4KIIβ/AP-1, this depends on the biosynthetic activity of PI4KIIβ; whereas, with PI4KIIα/AP-3, despite having a requirement for both kinase activity and an intact dileucine motif, evidence supporting a direct role for PtdIns4P in AP-3 recruitment has been elusive. However, the PI4KII isoforms synthesize spatially separate pools of PtdIns4P in the TGNendosomal system [11] ( Figure 1 ) and a pool of PtdIns4P is required for AP-3 cargo trafficking, [47, 48] arguing that both PI4K-adaptor systems are dependent on PtdIns4P. In summary, it is clear that PI4KII isoforms operate in different post-TGN trafficking pathways by utilizing distinct PI4KII-dependent clathrin adaptor systems, and that the PI4KIIα/AP-3 and PI4KIIβ/AP-1 complexes exhibit a similar reciprocal relationship between location and function.
Late Endosomal Traffic: Degradation or Recycling?
The epidermal growth factor receptor (EGFR) is a potent tyrosine kinase and significant human oncogene that, when activated, is rapidly downregulated by traffic to late endosomes (LEs). PI4KIIα is necessary for efficient EGFR trafficking and degradation, [35] and while PI4KIIα may play a role in trafficking the receptor into the LE pathway, the traffic of hydrolytic enzymes to the lysosome may also contribute indirectly to impaired degradation in siRNA-treated cells. [48] Furthermore, EGFR degradation is likely to be influenced by interaction of PI4KIIα with the ubitquitin proteosome system. PI4KIIα directly binds to the E3 ubiquitin ligase Itch at the TGN-endosome boundary, an interaction that increases Itch ubiquitin ligase activity while decreasing PI4KIIα activity. This interaction has important functional consequences for canonical Wnt signaling because the formation of the complex has the effect of facilitating the sorting of frizzled receptors for degradation, thereby determining the output of this major developmental signaling pathway. [42] After they exit the TGN, newly synthesized soluble hydrolases rely on mannose-6-phosphate receptors (M6PR) for delivery to lysosomes. [49] Depletion of either PI4KIIα or PI4KIIβ affects traffic of the cation-independent M6PR, which is an AP-1 cargo sorted to the LE through an AP-3 pathway, and it is likely that PtdIns4P generated by the PI4KII isoforms is responsible for this. [41, 46] PI4KIIα is required for co-trafficking of the lysosomal hydrolase β-glucocerebrosidase (GBA) and its receptor, the AP-3 cargo LIMP-2. GBA is essential for the metabolism of lysosomal glucosylceramide and mutations in GBA that affect binding to LIMP-2 lead to missorting and lysosomal accumulation of glucosylceramide. Interestingly, although PI4KIIα binds AP-3, and is clearly active in SE membranes, kinase dead PI4KIIα is able to partially rescue AP-3 trafficking defects. [43, 48] It is currently unclear why this phenomenon occurs but it is possible that an alternative activity is responsible for generating PtdIns4P at this locus.
Phagocytic cells use endosomal trafficking to deliver internalized pathogens and cell debris to the lysosome. As with endolysosomal traffic, phagosomes undergo maturation through early and late compartments, finally fusing with lysosomes. Two phases of PtdIns4P synthesis occur on maturing phagosomes: initially a transient phase, probably the result of PI4KIIIα activity, followed by a sustained phase that precedes lysosomal fusion that corresponds to the late stage of phagocytosis. Mature phagocytic membranes contain PI4KIIα, which synthesises PtdIns4P during this phase of maturation. [34, 50] This PtdIns4P pool presumably mediates traffic and fusion with lysosomes, probably by recruitment of the Rab7 effector RILP. An analogous heterotypic fusion process has been described involving the Atg8 family member γ-aminobutyric acid receptor-associated protein (GABARAP) that binds to and colocalizes with PI4KIIα on autophagic structures, along with PtdIns4P ( Figure 1) . [47, 51] siRNA of PI4KIIα or overexpression of the inactive kinase leads to the accumulation of enlarged autophagosomes, whose appearance can be phenocopied by GABARAP depletion. This phenotype can be rescued with exogenous PtdIns4P [51] ; therefore, the formation of large www.advancedsciencenews.com www.bioessays-journal.com autophagosomes may be due to preventing the local generation of PtdIns4P and the impairment of autophagosome-lysosome fusion. The parallels between the processes of phagocytosis and autophagy are clear and it is likely that the role of PI4KIIα in heterotypic fusion is conserved Table 1 .
PI4KIIs Determine the Fate of Cargoes through TGN Sorting and Endosomal Exit
PI4KIIα exists in varying amounts in the TGN, EE, LE, recycling compartments, and at the PM ( Figure 3A) . Mechanistic information on the trafficking steps that determine this broad subcellular distribution is, however, scarce. We know that siRNA of PI4KIIα results in the mislocalization of recycling [25] and late endosomal cargoes, [35, 45] and impaired sorting of the epidermal growth factor receptor (EGFR) and transferrin to degradative and recycling fates, respectively. [9] It appears that, rather than dynamic recruitment of the enzyme, the constitutively membrane-bound PI4KIIα is sorted, cargo-like, into different pathways through interaction with SNAREs. PI4KIIα binds to the R-snare VAMP3 on SEs where it facilitates retrograde delivery back to the TGN. Furthermore, the close homolog VAMP7 was identified as a component of AP-3 and PI4KIIα-containing vesicles, [43] where it mediates fusion with the LE. Thus converging evidence supports a role for SNAREs and PI4KIIα in sorting into retrograde recycling and LE pathways, probably determining the balance of traffic between these diverging routes ( Figure 3A) .
The association of PI4KII with membranes derived from secretory tissues is well documented and extracts of these have proved to be rich sources of activity. [7, 12] Aside from the work describing PI4KII in the control of post-TGN and endosomal trafficking, there is also a substantial body of work supporting a role for PI4KIIα in traffic toward the PM (Table 2; Figure 3A ). An explanation for this is provided by the fact that endosomal compartments can serve as intermediates in trafficking to the plasma membrane, particularly in specialized secretory cells. [52] Such a pathway has been described originating at EE/SEs ( Figure 3A ) that involves the PtdIns3P-phosphatase myotubularin 1 (MTM1). [53] Hydrolysis of endosomal PtdIns3P is required during the exocytotic step returning the unloaded TfR to the plasma membrane. Failure to hydrolyze PtdIns3P results in impaired exit from endosomes, and consequently, the accumulation of exocytic cargoes. Normally, MTM1 is recruited to PtdIns3P-containing EE/SEs that also harbor PI4KIIα [25, 35, 54] and when PtdIns3P is hydrolyzed, the PtdIns produced becomes a substrate for resident PI4KIIα. In the context of a membrane in which the supply of PtdIns may be limited, and where the local environment is optimal for kinase activity, then the result would be increased local PtdIns4P synthesis, effectively converting PtdIns3P on EE/ SEs into PtdIns4P. This is a significant switch in membrane identity because PtdIns3P-positive endosomes are unable to fuse with the PM; however, vesicles containing PtdIns4P, that arise from the closely connected RE, can ( Figure 3A) . [53] Generation of PtdIns4P also leads to recruitment of the exocyst complex, which interacts with PI4KIIα. Exocyst mediates the docking and membrane insertion of exocytic and recycling cargoes such as TfR and integrin β1; therefore, MTM1 and PI4KIIα forms a conversion module controlling endosomal exocytosis by switching PI metabolism from PtdIns3P to PtdIns4P. It also shows that PI4KIIα is a more versatile enzyme that functions, not only in trafficking to the LE and terminal processes such as lysosomal fusion but also in anterograde traffic.
PI4KII-Mediated Traffic is Linked to the Actin Cytoskeleton
Numerous actin-binding proteins interact both with PIs and elements of endocytic machinery, thereby linking PI metabolism with actin dynamics in membrane trafficking processes. For example, actin polymerization is required to propel newly endocytosed cargoes though the cytoplasm on comet-like structures, [55, 56, 57] and requirements for actin polymerization have been identified in LE to lysosomal traffic and in recycling. The Wiskott-Aldrich syndrome (WAS) family of actin branching regulators are targets of PtdIns(4,5)P 2 that are frequently implicated in endosomal trafficking pathways. [58] A clue that Trafficking process References TGN > PM [41] EE/SE > RE > PM [53] LE > PM [80] Glut4 > PM [82] Mast cell degranulation [83] Regulated secretion [84, 85] Secretory granule formation [86] Summary of evidence showing PI4KIIα in traffic toward the PM.
www.advancedsciencenews.com www.bioessays-journal.com PI4KII enzymes may have a conserved role in actin-dependent endocytic traffic comes from the sole PI4KII homolog of the yeast S. cerevisiae, Lsb6, which is a binding protein of the yeast Wiskott-Aldrich syndrome protein (WASp) homolog Las17. [59] During phagocytosis and Listeria monocytogenes infection, movement through the cytoplasm is accompanied by the dynamic formation of actin-rich comets. These require the coordinated activities of actin nucleating machinery ARP2/3, Ena-VASP, and WASp. Both PI4KII isoforms are recruited to internalized beads coated with the bacterial cell surface protein InlB and these pseudophagosomes become decorated with PtdIns4P. [60] PI4KIIα exists in complex with a large number of actin regulatory proteins including RhoGEF1 and several subunits of the actin nucleation promoting WASH complex, [42, 54] which, together with Arp2/3, regulates endosome morphology and trafficking. [61] PI4KIIα also colocalizes with fluorescent actin on EEs that contain branched actin. The close association of PI4KIIα with actin regulatory machinery and the necessity for PtdIns4P synthesis on endosomes together suggests that PI4KIIα participates in the synthesis of an EE pool of PtdIns(4,5)P 2 . In support of this, we recently demonstrated that PtdIns4P and PtdIns(4,5)P 2 exist in separate endosomal microdomains and that PI4KIIα is required for correct early endosomal sorting of the EGFR and Tf through the synthesis of PtdIns4P. [9] PtdIns(4,5)P 2 levels in the EE are controlled by the PtdIns(4,5)P 2 5-phosphatase OCRL, depletion of which leads to an N-WASpdependent increase in endosomal F-actin and consequently the mistrafficking of TfR, EGFR, and M6PR. [62] Ectopic accumulation of PtdIns4P and PtdIns(4,5)P 2 is also observed when PtdIns4P hydrolysis by the PtdIns4P phosphatase Sac1 is inhibited at endosome-ER contacts, resulting in aberrant trafficking of retrograde cargoes. [63] Interestingly, the activity of OCRL is also required on SEs to maintain correct traffic of multiple endosomal cargoes. [62] Together this evidence demonstrates the importance of regulating the levels of endosomal PtdIns4P and PtdIns(4,5)P 2 and, as the principal sources of early endosomal PtdIns4P, the PI4KIIs are likely to assume greater importance at this site in the future.
PI4KIIs Modulate Wnt Signaling
Wnt ligands control major developmental signaling cascades that are frequently dysregulated in human cancers. [64] Both PI4KIIα and type Iβ phosphatidylinositol 4-phosphate 5-kinase (PIP5KIβ) bind to, and are activated by, the Wnt scaffolding protein Dvl in a multiprotein complex synthesizing PtdIns(4,5)P 2 .
[65] Knockdown of PI4KIIα causes axis duplication in Xenopus, [66] a developmental defect linked to aberrant Wnt signaling. Another study showed that knockdown of PI4KIIα impaired the internalization, endosomal traffic, and degradation of the Wnt receptor frizzled (Fz) 4. [42] It is therefore likely that PI4KIIα is involved in at least two regulatory steps in canonical Wnt signaling: the formation of an activated signaling complex with Dvl promoting PM PtdIns(4,5)P 2 synthesis at the PM and in a sorting complex that facilitates traffic to degradative compartments.
Knockdown of Zebrafish PI4KIIβ affects Wnt target gene expression and causes developmental defects. In cell lines, the kinase exists in a complex with Dvl and axin1, both components of the canonical Wnt signaling cascade. Depletion of PI4KIIβ leads to accumulation of endocytosed Fz in LEs, probably in transit for degradation. This accumulation can be rescued by ectopic expression of PI4KIIβ but not with a mutant incapable of AP-1 binding, indicating that AP-1 dependent trafficking underlies the phenomenon. Consistent with this, the AP-1 complex is known to be important for traffic to basolateral domains of epithelial cells [67] in developing embryos and interference with AP-1 perturbs the Wnt planar cell polarity (PCP) pathway [68] important for organization of embryonic tissues.
PI4KIIs are Associated With Cancer
Both elevated and reduced levels of PI4KIIα expression are associated with cancers. For example, elevation has been detected in a diverse panel of human tumors and increasing PI4KIIα expression was observed during the development of tumors in a mouse xenograft model. [69] Meanwhile, ectopic overexpression of PI4KIIα but not a kinase dead mutant was sufficient to induce expression of HIF-1α, an important factor allowing cells to survive the hypoxic tumor environment. The same group subsequently showed that PI4KIIα siRNA leads to degradation of Her2 and EGFR, and overexpression to Her2 activation. [70] While the data supporting the hypothesis that PI4KIIα positively regulates EGFR levels and signaling is comprehensive and compelling, it is at odds with the established LE roles of PI4KIIα and in regulating the degradation of the EGFR [35] and the fact that loss rather than gain of the PI4K2A gene is associated with an aggressive brain cancer. [71] However, PI4KIIα depletion studies have revealed complex effects on both the supply of PtdIns4P for signaling and membrane trafficking. [72] Thus it is likely that these discrepancies may reflect the inherent heterogeneity of tumors; nevertheless, it is clear that the dual targeting of EGFR family kinases and PI4KIIα holds some promise as a personalized chemotherapeutic approach in certain cancers. [70] PI4KIIβ has been implicated in regulation of cell migration and metastasis of hepatocellular carcinoma through interaction with the tetraspanin CD81, [73] a molecule that has been shown previously to co-purify with PI4KII activity. [74] siRNA of PI4KIIβ leads to the formation of invasive structures, increased extracellular matrix degradation by the matrix type I metalloproteinase (MT1-MMP) and increased motility through collagen gels, thus indicating that PI4K2B has properties consistent with a suppressor of metastasis. In the same work, oncogenomic studies identified PI4KIIβ loss as a risk factor in cancer. [11] 
PI4KIIα is Linked to Neurological Disease
Loss of PI4KIIα in mice leads to impaired neurological function resembling human spastic paraplegia, eventually resulting in premature death. [75] It is difficult to pinpoint a single trafficking step that may account for these defects given that PI4KIIα functions in LE, retrograde traffic and exocytosis but, in addition to axonal pathology, the mice show accumulation of lipofuscinlike deposits and membrane inclusions. This is consistent with deficient LE traffic or EE/SE exit to the Golgi [47, 48] (Figure 4 ) and such trafficking defects would explain the axonal degeneration and neuron loss in these mice.
Aberrant endolysosomal traffic is frequently associated with late onset neurodegenerative diseases. [76] As mentioned above, PI4KIIα is responsible for the traffic of GBA from the TGN to endosomes where the complex is routed to lysosomes. Failure of this hydrolase to reach lysosomes results in failure to catabolize glucosylceramide and the accumulation causing Gaucher disease, the most common human lysosomal storage disease.
The ability PI4KIIα to bind AP-3 and recruit the clathrin adaptor to membranes has important implications for traffic to lysosomes and lysosomal-related organelles. Hermansky-Pudlak syndrome is a rare autosomal recessive disease characterized by albinism and bleeding disorders. Like hereditary spastic paraplegia, Hermansky-Pudlak syndrome is genetically heterogeneous and can result from mutation in a number of loci encoding proteins involved in endolysosomal traffic. Clinical presentation and histopathology shows little in common with hereditary spastic paraplegia, but like the PI4KIIα mouse knockout, lipofuscin deposition can be observed in some tissues. The adaptor complex AP-3 is just one gene affected in Hermansky-Pudlak syndrome, and PI4KIIα associates with multiprotein complexes known to be involved in Hermansky-Pudlak syndrome. [77] Loss of function mutations of the MTM1 gene encoding a PI3-phosphatase leads to X-linked centronuclear myopathy (XLCNM), a severe congenital neuromuscular disease. As discussed previously, hydrolysis of endosomal PtdIns3P and salvage of the PtdIns formed by PI4KIIα appears to be a prerequisite for exocytic trafficking to the plasma membrane (Figure 4) . Specific inhibitors for the PI3-kinase hVPS34 have been developed and were shown to restore exocytic traffic to the PM, [53] suggesting that they could form the basis for treatment of XLCNM.
Cholesterol, a membrane constituent and activator of PI4KIIα, has long been implicated in the pathogenesis of Alzheimer's disease. [78] Steroid-like natural ginsenosides can reduce the accumulation of the amyloidogenic Aβ in cultured neurons and the brains of an Alzheimer's mouse model, while enhancing the activity of PI4KIIα and increasing the levels of PtdIns4P and PtdIns(4,5)P 2 in cultured cells. [79] Cholesterol and sterol analogs are able to activate PI4KIIα, [17] and although PI4KIIα has not been directly implicated in the pathology of Alzheimer's disease in recent gene studies, a plausible therapeutic strategy might be the up-regulation PI4KIIα activity, or the inhibition of PI 4-phosphatases, to protect against the development of AD. However, testing this hypothesis would require exceptionally demanding longitudinal studies.
Conclusions: Integrating PI4KII Functions
The discovery of PtdIns4P on early and late endosomes, as well as the TGN, challenges the prevailing view that PtdIns3P is an exclusive determinant of endosomal membrane identity. It is now clear that PtdIns4P synthesis by PI4KII isoforms at these membranes performs decisive roles in cargo selection, sorting and in directing traffic. In early endosomes, PtdIns3P can be converted to PtdIns4P via dephosphorylation to the common PtdIns precursor to accomplish endosomal exit and traffic toward the plasma membrane. A similar relationship between PtdIns3P and PtdIns4P has been noted during phagosomal maturation, suggesting that comparable conversion mechanisms exist in other trafficking pathways. Also, local PtdIns4P synthesis by PI4KIIs can recruit different clathrin adaptors thereby controlling the traffic of different cargoes into distinct pathways and adding to the complexity of PI4KII trafficking.
Close membrane interaction as a result of palmitoylation is the principal determinant of PI4KII activity at membrane interfaces. Unlike all known PI kinases, which are invariably recruited to membranes containing their substrates, PI4KIIα is constitutively membrane associated. The emerging model then is one in which membrane-bound PI4KIIα is highly sensitive to its membrane environment, responding to activation with the local synthesis of PtdIns4P. PI4KIIα activity can be further modulated in situ through the binding of proteins such as Itch that can regulate activity. Therefore, PI4KIIα appears to be a sensor capable of reacting to changes in membrane Figure 4 . PI4KII trafficking pathways of relevance to human disease. Five main pathways are affected by loss of PI4KII function in in vitro or whole animal models: TGN-to-endosomal traffic (i) is affected in zebrafish that have lost PI4KIIβ, resulting in developmental defects attributed to aberrant Wnt signaling [46] ; (ii) loss of PI4KIIα impairs endosome-to-TGN traffic facilitated by VAMP3 [47] ; endolysosomal traffic (iii) is affected by knockdown of PI4KIIα, which impairs degradation of lysosomal cargoes such as the EGFR, [35] the traffic of lysosomal membrane proteins [48] and lysosome-related organelles [81] and likely causes a phenotype in mice that is reminiscent of human spastic paraplegia (HSP [75] ). Note that this phenotype may reflect a defect in a lysosomal pathway or a retrograde step (i.e., b); (iv) endosome-to-plasma membrane traffic controlled by PI4KIIα is affected by in human X-linked centronuclear myopathy (XLCNM) [53] ; (v) LE-to-PM. PI4KIIα is trafficked from the LE to the PM in HIV infected Tcells. [80] Note that both PI4KIIα and PI4KIIβ function in pathways that can culminate in traffic to the lysosome; therefore, knockdown of either isoform can give similar late endosomal/lysosomal phenotypes, leading some to conclude they have overlapping functions.
www.advancedsciencenews.com www.bioessays-journal.com environment, such as cholesterol content and the local availability of PtdIns, with increased synthesis of PtdIns4P. In this way, PI4KIIα activity recruits PtdIns4P effector proteins, alters membrane identity and redirects traffic from the EE/SE in specific directions such as toward the LE, Golgi or PM. The implication here is that membranes containing active PI4KIIα could respond in a similar way to many other metabolic activities generating PtdIns. Insight into the biology of PI4KIIβ has lagged behind but it is clear that this isoform, in contrast to PI4KIIα, can be regulated by extrinsic factors. Extracellular signals trigger membrane recruitment of the enzyme and therefore control its activity. The plasma membrane location of PI4KIIβ is intriguing because it implies a function for PtdIns4P synthesis at the PM, a role currently reserved for PI4KIIIα. Also, it is not clear how PI4KIIβ is specifically targeted to the plasma membrane by palmitoylation alone, and it is possible that additional factors are required. It is likely that PI4KIIβ functions in developmental Wnt signaling at the plasma membrane, possibly by maintaining epithelial cell polarity and suppressing a migratory program. In support of this, loss of the enzyme is a risk factor in human cancers, which is also consistent with the notion that PI4KIIβ is highly regulated under physiological conditions.
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